Diagnosis, prevention, medicine

The production of ELISA test systems for the assessment of acute conditions of DIA®-CRP and DIA®-D-dimer, for the quantitative...

The standard of medical care "Coronavirus infection" is constantly updated, almost monthly, taking into account the updated...

Diaproph-Med co-authored with a wide range of world specialists in the fields of biotechnology, virology and public health published an...

On July 28, 2021, PJSC “SPC “DIAPROPH-MED” passed an unannounced inspection by the state surveillance sector of State Service of Ukraine...

A new ELISA test DIA®-SARS-CoV-2-nAb for qualitative and semi-quantitative detection of spike neutralizing antibodies in human serum and...

PJSC “SPC “Diaproph-Med” in accordance with the requirements of the international quality management standard ISO13485, conducted a...

The scientific department under the leadership of academician N. Spivak together with the Institute of Microbiology and Virology named...

On June 9, 2021, under the chairmanship of the President of the NAS of Ukraine, Academician Anatoliy Zagorodny, a regular meeting of the...

On June 9, 2021, under the chairmanship of the President of the NAS of Ukraine, Academician Anatoliy Zagorodny, a regular meeting of the...

On June 8, 2021, Diaprof-Med passed an unscheduled inspection by the State Service of Ukraine for Medicines and Drug Control. The subject...

The catalog has been updated on the site! You can familiarize yourself with him in the section "Catalog". To correct the commercial...

On May 26, 2021, Diaprof-Med will take part in the Scientific and Practical Conference with International Participation "Status and...

DIAPROF MED has successfully passed a recertification audit in order to confirm the conformity of products bearing the CE mark with the...

(USREOU code 24265186, location: 03113, Kyiv, 68/1 Peremohy Ave., office 62) (hereinafter - the Company) announces the convening of the...